These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22923651)

  • 1. Loss of pulsatile insulin secretion: a factor in the pathogenesis of type 2 diabetes?
    Wahren J; Kallas Å
    Diabetes; 2012 Sep; 61(9):2228-9. PubMed ID: 22923651
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes: the importance of the liver.
    Rutter GA
    Curr Biol; 2000 Oct; 10(20):R736-8. PubMed ID: 11069096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.
    DeFronzo RA
    Diabetologia; 1992 Apr; 35(4):389-97. PubMed ID: 1516769
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance in non-insulin-dependent diabetes mellitus. A review.
    Alzaid AA
    Acta Diabetol; 1996 Jul; 33(2):87-99. PubMed ID: 8870808
    [No Abstract]   [Full Text] [Related]  

  • 6. The direct and indirect effects of insulin on hepatic glucose production in vivo.
    Cherrington AD; Edgerton D; Sindelar DK
    Diabetologia; 1998 Sep; 41(9):987-96. PubMed ID: 9754815
    [No Abstract]   [Full Text] [Related]  

  • 7. [The pulsatility of insulin secretion. Two distinct circadian rhythms].
    Simon C; Brandenberger G
    Rev Prat; 1994 Mar; 44(6):791-4. PubMed ID: 8059218
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of obesity on the pathogenesis of non-insulin-dependent diabetes mellitus: a review of current hypotheses.
    Pedersen O
    Diabetes Metab Rev; 1989 Sep; 5(6):495-509. PubMed ID: 2670490
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of the insulin receptor kinase in the effect of insulin and pathogenesis of type II diabetes].
    Häring HU
    Z Gastroenterol Verh; 1991 Mar; 26():229. PubMed ID: 1714157
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of inverse relationship between pulsatile insulin and glucagon secretion in patients with type 2 diabetes.
    Menge BA; Grüber L; Jørgensen SM; Deacon CF; Schmidt WE; Veldhuis JD; Holst JJ; Meier JJ
    Diabetes; 2011 Aug; 60(8):2160-8. PubMed ID: 21677283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulsatile secretion of insulin.
    Husain M
    N Engl J Med; 1988 Oct; 319(16):1094-5. PubMed ID: 3050520
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
    Evans AJ; Krentz AJ
    Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
    [No Abstract]   [Full Text] [Related]  

  • 13. High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology.
    Schmitz O; Brock B; Hollingdal M; Juhl CB; Pørksen N
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S14-20. PubMed ID: 12703061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo regulation of pulsatile insulin secretion.
    Pørksen N
    Diabetologia; 2002 Jan; 45(1):3-20. PubMed ID: 11845219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance.
    Ritzel R; Schulte M; Pørksen N; Nauck MS; Holst JJ; Juhl C; März W; Schmitz O; Schmiegel WH; Nauck MA
    Diabetes; 2001 Apr; 50(4):776-84. PubMed ID: 11289042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes.
    Withers DJ; White M
    Endocrinology; 2000 Jun; 141(6):1917-21. PubMed ID: 10830270
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.
    Adiels M; Westerbacka J; Soro-Paavonen A; Häkkinen AM; Vehkavaara S; Caslake MJ; Packard C; Olofsson SO; Yki-Järvinen H; Taskinen MR; Borén J
    Diabetologia; 2007 Nov; 50(11):2356-65. PubMed ID: 17849096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dysregulation of glucagon secretion in diabetes and intra-islet insulin effect on alpha-cells].
    Kawamori D
    Nihon Rinsho; 2012 May; 70 Suppl 3():212-7. PubMed ID: 22768522
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy.
    Meier JJ; Pennartz C; Schenker N; Menge BA; Schmidt WE; Heise T; Kapitza C; Veldhuis JD
    Diabetes Obes Metab; 2013 Mar; 15(3):258-63. PubMed ID: 23039360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
    Mauvais-Jarvis F; Kahn CR
    Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.